4py4
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='4py4' size='340' side='right' caption='[[4py4]], [[Resolution|resolution]] 2.76Å' scene=''> | <StructureSection load='4py4' size='340' side='right' caption='[[4py4]], [[Resolution|resolution]] 2.76Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4py4]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4PY4 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4PY4 FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[4py4]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4PY4 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4PY4 FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=XL2:2-({4-[(1R)-1-(DIMETHYLAMINO)ETHYL]PHENYL}AMINO)-6-FLUORO-1,3-BENZOTHIAZOLE-4-CARBOXAMIDE'>XL2</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=XL2:2-({4-[(1R)-1-(DIMETHYLAMINO)ETHYL]PHENYL}AMINO)-6-FLUORO-1,3-BENZOTHIAZOLE-4-CARBOXAMIDE'>XL2</scene></td></tr> | ||
| + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">PARP14, BAL2, KIAA1268 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> | ||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/NAD(+)_ADP-ribosyltransferase NAD(+) ADP-ribosyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.30 2.4.2.30] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/NAD(+)_ADP-ribosyltransferase NAD(+) ADP-ribosyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.30 2.4.2.30] </span></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4py4 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4py4 OCA], [http://pdbe.org/4py4 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4py4 RCSB], [http://www.ebi.ac.uk/pdbsum/4py4 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4py4 ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4py4 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4py4 OCA], [http://pdbe.org/4py4 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4py4 RCSB], [http://www.ebi.ac.uk/pdbsum/4py4 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4py4 ProSAT]</span></td></tr> | ||
| Line 10: | Line 11: | ||
== Function == | == Function == | ||
[[http://www.uniprot.org/uniprot/PAR14_HUMAN PAR14_HUMAN]] Enhances STAT6-dependent transcription (By similarity). Has ADP-ribosyltransferase activity. | [[http://www.uniprot.org/uniprot/PAR14_HUMAN PAR14_HUMAN]] Enhances STAT6-dependent transcription (By similarity). Has ADP-ribosyltransferase activity. | ||
| - | |||
| - | ==See Also== | ||
| - | *[[Poly (ADP-ribose) polymerase|Poly (ADP-ribose) polymerase]] | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: Human]] | ||
[[Category: Li, J]] | [[Category: Li, J]] | ||
[[Category: Xu, Y]] | [[Category: Xu, Y]] | ||
Revision as of 07:29, 6 December 2017
Crystal structure of human poly(ADP-ribose) polymerase 14, catalytic domain in complex with an inhibitor XL2
| |||||||||||
